VCIM
MIST icon

Velan Capital Investment Management’s Milestone Pharmaceuticals MIST Stock Holding History

Velan Capital Investment Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-650,000
Closed -$1.16M – 23
2024
Q1 		$1.16M Buy
+650,000
New +$1.06M 0.53% 17

Other funds holding MIST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Velan Capital Investment Management's MIST Position: Q2 2024 in Review

Velan Capital Investment Management sold out of Milestone Pharmaceuticals (MIST) in Q2 2024, closing a stake of 650,000 shares — an estimated $1.16M sold.

Velan Capital Investment Management first reported a position in MIST in Q1 2024 and held it in 1 quarter. The position peaked at $1.16M in Q1 2024. 40 funds tracked by Wall St. Rank hold MIST as of Q2 2024.

  • Velan Capital Investment Management reported no remaining Milestone Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Velan Capital Investment Management sold 650,000 Milestone Pharmaceuticals shares in Q2 2024, an estimated $1.16M.
  • Velan Capital Investment Management first reported a position in Milestone Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Velan Capital Investment Management's Milestone Pharmaceuticals position peaked at $1.16M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2024.

Based on Velan Capital Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.